Phillip Davis
Seminars
Thursday 23rd July 2026
Navigating Regulatory Complexities in Radiopharmaceutical Development
8:00 am
- Clarifying the unique regulatory requirements for radiopharmaceuticals versus conventional therapies like ADCs
- Aligning early-phase trial designs with risk-based, patient-centric approaches to accelerate first-in-human studies
- Facilitating global harmonization by comparing regulatory frameworks in the US, Europe, China, and Australia to reduce development delays
